Octreotide and mTOR inhibitor treatment suppressed cell proliferation by inhibiting AKT-mTOR-p70S6K pathway activation in neuroendocrine tumor cell lines [44]. Here, RPS6KB1 is linked to neuroendocrine neoplasm.